Skip to content

Lucid Diagnostics LUCD Operating Cash Flow

Operating Cash Flow at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$22.13M-267%
Guardant Health logo
Guardant HealthGH
-$65.62M-4.7%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$10.17M-18.2%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-$7.64M-30.8%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$7.1M+260%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$22.48M-25.1%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's operating cash flow?
Lucid Diagnostics (LUCD) reported operating cash flow of -$12.1M in Q1 2026.
How has Lucid Diagnostics's operating cash flow changed year-over-year?
Lucid Diagnostics's operating cash flow increased by 2.9% year-over-year, from -$12.47M to -$12.1M.
What is the long-term trend for Lucid Diagnostics's operating cash flow?
Over 4 years (2021 to 2025), Lucid Diagnostics's operating cash flow has grown at a 27.4% compound annual growth rate (CAGR), from -$17.67M to -$46.49M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.